NURS 3100 Exam 1 Practice

Why do some medications get approved by the FDA faster than others?

1. Pharmaceutical companies are allowed to skip the preclinical investigation phase if they are developing a chemotherapy drug

2. A smaller group of patients with a particular disease are selected for the clinical phase trials

3. The accelerated approval program allows earlier approval if it is a commonly used drug

4. The FDA collects a user fee from pharmaceutical companies to hire more employees and speed up the process

The correct answer is: Pharmaceutical companies are allowed to skip the preclinical investigation phase if they are developing a chemotherapy drug

Some medications may get approved by the FDA faster than others due to a few reasons. Option A is correct because pharmaceutical companies can skip the preclinical investigation phase if they are developing a chemotherapy drug. However, this does not necessarily mean that the medication is less safe or effective. Option B is not relevant as the size of the patient group does not impact the speed of FDA approval. Option C is also incorrect because the accelerated approval program does not solely rely on the drug's popularity but rather its potential to treat a serious condition. Option D is also incorrect because while user fees may fund the FDA, they do not necessarily speed up the process. Therefore, all other options are not directly related to the speed of FDA approval compared to Option A.